MedPath

To study the efficacy of Tulsi swarasadi Taila and Durvadya Taila in Atopic Dermatitis.

Phase 1
Conditions
Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
Registration Number
CTRI/2024/01/061622
Lead Sponsor
PDEAS College Of Ayurved and Research Centre nigdi pune
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient having symptoms of atopic dermatitis-Dry skin(Rukshata of twak),Itching(Kandu),Erythema(Raktavarnata of twak) and Eruption(Pidaka)-two or more of these symptoms should be present

2.Children between the age group of 1 to 12 years,irrespective of sex.

Exclusion Criteria

1.Weeping eczemas,infected lesion will be excluded from the study.

2.Lichenified skin changes.

3.Childern having any other associated illness like diarrhea,acute respiratory infections and acute febrile illness or other disorders will be excluded from the study.

4.Lesions greater than 9% body surface area.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the efficacy of external application of Tulsi swarasadi Taila in the management of atopic dermatitis for 15 days in childern (1 to 12 years)for itching.Timepoint: 15 days where follow up on 7th day,15th day.
Secondary Outcome Measures
NameTimeMethod
To observe adverse effects if any in 15 daysTimepoint: 15 days where follow up on 7th day,15th day.
© Copyright 2025. All Rights Reserved by MedPath